Maryam Adas

Maryam Adas is a postdoctoral research fellow at King's College London's Department of Inflammation Biology within the Faculty of Life Sciences & Medicine. With 496 citations across 26 research outputs including 23 articles, 2 review articles, and 1 letter, she has established herself as an emerging researcher in rheumatology and inflammatory diseases.

Her research profile shows expertise in rheumatoid arthritis, inflammatory arthritis, and treatment outcomes, with particular focus on disease-modifying antirheumatic drugs (DMARDs), cohort studies, and meta-analyses. Her fingerprint analysis reveals strong activity in Rheumatoid Arthritis (100%), Inflammatory Arthritis (100%), Cohort Study (48%), Cohort Analysis (46%), and COVID-19 (45%) related research.

Dr. Adas recently completed her doctoral thesis titled 'Clinical and non-clinical outcomes of patients with early rheumatoid arthritis' under supervisors Professor Jonathan B. Galloway and Dr. Simon Norton. Her current research examines treatment initiation patterns, infection risks, and long-term outcomes in inflammatory arthritis patients through large UK-based cohort studies.

Her publication record demonstrates significant impact with multiple high-profile papers in 2025 including in The Lancet Rheumatology and Rheumatology journal, covering topics from drug safety to healthcare disparities in underserved populations. Her work contributes to UN Sustainable Development Goals related to good health and well-being.